Ani pharmaceuticals q2 adjusted non-gaap earnings per share $0.69

Ani pharmaceuticals reports second quarter 2020 results.q2 adjusted non-gaap earnings per share $0.69.q2 gaap loss per share $1.03.q2 revenue $48.5 million versus refinitiv ibes estimate of $46.9 million.ani pharmaceuticals - cash, equivalents were $27.7 million, net accounts receivable was $73.2 million, debt was $190.2 million as of june 30.suspended previously announced 2020 financial guidance.
ANIP Ratings Summary
ANIP Quant Ranking